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Abstract
Objective To characterise the complete case series of influenza A/H7N9
infections as of 27 May 2013, detected by China’s national sentinel
surveillance system for influenza-like illness.
Design Case series.
Setting Outpatient clinics and emergency departments of 554 sentinel
hospitals across 31 provinces in mainland China.
Cases Infected individuals were identified through cross-referencing
people who had laboratory confirmed A/H7N9 infection with people
detected by the sentinel surveillance system for influenza-like illness,
where patients meeting the World Health Organization’s definition of
influenza-like illness undergo weekly surveillance, and 10-15
nasopharyngeal swabs are collected each week from a subset of patients
with influenza-like illness in each hospital for virological testing. We
extracted relevant epidemiological data from public health investigations
by the Centers for Disease Control and Prevention at the local, provincial,
and national level; and clinical and laboratory data from chart review.
Main outcomemeasureEpidemiological, clinical, and laboratory profiles
of the case series.
Results Of 130 people with laboratory confirmed A/H7N9 infection as
of 27May 2013, five (4%) were detected through the sentinel surveillance
system for influenza-like illness. Mean age was 13 years (range 2-26),
and none had any underlying medical conditions. Exposure history,
geographical location, and timing of symptom onset of these five patients
were otherwise similar to the general cohort of laboratory confirmed
cases so far. Only two of the five patients needed hospitalisation, and
all five had mild or moderate disease with an uneventful course of
recovery.
Conclusion Our findings support the existence of a “clinical iceberg”
phenomenon in influenza A/H7N9 infections, and reinforce the need for
vigilance to the diverse presentation that can be associated with A/H7N9
infection. At the public health level, indirect evidence suggests a
substantial proportion of mild disease in A/H7N9 infections.
Introduction
A common feature of influenza disease is the “clinical iceberg”
phenomenon, which states that many mild cases of infection
escape clinical detection owing to the lack of severe symptoms
presented.1 This phenomenon is certainly true for interpandemic
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influenza2 as well as for the influenza A/H1N1 pandemic in
2009.3 However, A/H5N1 is an acknowledged exception,4
whereas the A/H7N7 outbreak in the Netherlands suggested
that there was a large submerged portion of the iceberg, but
which was not as substantial as that for other interpandemic
human strains.5 6
The influenza A/H7N9 virus emerged in early 2013, and people
with infections initially confirmed in the laboratory were
admitted to hospital with serious illness.7 8 Most laboratory
confirmed infections have been found in residents of urban
areas, who have reported recent exposure to live poultry,9 10 and
investigations of live poultry markets have identified a high
prevalence of influenza A/H7N9 virus in poultry.11 However,
comparison of the incidence of laboratory confirmed cases with
patterns in exposure suggests that seriousness of infection may
increase with age, and that somemild infections may have gone
undetected in younger adults.12 13 In addition, a small number
of laboratory confirmed cases have been identified through
China’s national sentinel surveillance system for influenza-like
illness.14
Here, we describe the clinical characteristics of all patients with
A/H7N9 infections as of 27 May 2013, who were identified
through routine testing by the sentinel surveillance system for
influenza-like illness. These findings could indicate the sizable
proportion of people with milder infections and who would
otherwise not have been detected, which would be important if
present circulating strains of A/H7N9were to acquire the ability
to spread efficiently among humans. Moreover, there is an
urgent need to better understand how these patients may present
at the clinical interface, and if they represent a separately
identifiable group. The objective of our study was to characterise
the complete case series of A/H7N9 infections as of 27 May
2013, identified through China’s national sentinel surveillance
system for influenza-like illness.
Methods
Sources of cases
All laboratory confirmed A/H7N9 infections are reported to the
Chinese Center for Disease Control and Prevention through a
national sentinel surveillance system. Case definitions,
surveillance for identification of A/H7N9 cases, and laboratory
test assays have been described in a previous report.9 A joint
field investigation team—comprising staff of the Centers for
Disease Control and Prevention at the local, provincial, and
national level—conducted field investigations of the laboratory
confirmed cases of A/H7N9 virus infection.
Surveillance of influenza-like illness in China
Surveillance of influenza-like illness and its associated virology
in China is conducted through a national sentinel network across
the country. The network consists of outpatient clinics and
emergency departments of 554 sentinel hospitals across 31
provinces in mainland China, covering 2.5% of all hospitals in
China. Data for cases of influenza-like illness included the total
number of outpatient or emergency department visits, and the
number of patients fitting the World Health Organization’s
standard case definition of influenza-like illness (that is, body
temperature ≥38°C with either a cough or sore throat in the
absence of an alternative diagnosis) is reported on a weekly
basis through a centralised online system to the Chinese Center
for Disease Control and Prevention.
For each sentinel site, 10-15 nasopharyngeal swabs are collected
each week by convenience samples of patients with
influenza-like illness who had not taken antiviral drugs and who
had fever (>38°C) for no longer than three days. These swabs
undergo routine virological testing and subtyping, and results
are reported to the Chinese Center for Disease Control and
Prevention within 24 h.15 Surveillance is conducted throughout
the year to systematically collect data all year round with a
consistent sampling frame. Outpatient clinics or emergency
departments in hospitals represent a typical first step for patients
with influenza-like illness in China to present to the healthcare
system, owing to the coverage of national health insurance
programmes and the lack of standalone primary healthcare
clinics in either the public or private sector as an alternative.
Although the selection of patients with influenza-like illness
for virology testing was not random, there should not have been
any incentive for selection according to clinical severity, because
results would not have been fed back to doctors for treatment
purposes. Therefore, the sentinel surveillance system for
influenza-like illness is believed to capture typical patients in
the community, and thought to give a representative picture of
the disease in China.
By cross-referencing the laboratory confirmed cases of A/H7N9
infection with patients detected by the sentinel surveillance
system for influenza-like illness, we could identify all infected
patients detected through the surveillance system as of 27 May
2013.We extracted demographic and epidemiological data from
public health investigations by the local, provincial, and national
level Centers for Disease Control and Prevention; and clinical
and laboratory data from chart review.
Results
Among the 130 laboratory confirmed cases of A/H7N9 infection
as of 27 May 2013, five patients were first identified through
the sentinel surveillance system for influenza-like illness. The
earliest laboratory confirmed cases occurred in the Yangtze
River Delta, and more recent cases were detected to the north
and south. Figure 1⇓ shows the geographical location of 130
confirmed cases, and the five cases detected through sentinel
surveillance. Figure 2⇓ shows the timing of illness onset in those
five cases compared with the other laboratory confirmed cases
in affected provinces.
Clinical characteristics
The five patients identified by the sentinel surveillance system
for influenza-like illness (patients 1-5) ranged in age from 2 to
26 years (mean 13 years), of whom four (80%) were male. They
lived in urban areas of three different provinces. Date of
symptom onset ranged from 17 March to 26 April 2013. Three
patients were young children, and four had a confirmed history
of exposure to live animals, including chickens. All presented
with fever, and most with upper respiratory tract symptoms.
Four were captured by the surveillance system within the next
day, and one within two days of symptom onset. All five patients
had mild to moderate disease and have since recovered. Among
them, three (60%) were managed only as outpatients, and the
other two (40%) were admitted to hospital and subsequently
discharged. One patient had pneumonia without requiring
intensive care. All close contacts of these five patients underwent
medical surveillance and had remained well. Figure 3⇓
summarises key clinical milestones of each patient, and table
1⇓ shows their epidemiological characteristics.
Patient 1 was a 2 year old child from Shanghai, patient 3 was
a 26 year old woman from Jiangsu, and patient 5 was a 9 year
old primary school student from Fujian. Patients 3 and 5 had a
history of poultry exposure. They all presented with fever and
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were seen within one day of symptom onset in a designated site
of the sentinel surveillance system for influenza-like illness.
Nasopharyngeal swabs were taken, as part of the 10-15 routine
samples per week for virological surveillance. Because patients
1, 3, and 5 all had a mild presentation, they were not suspected
to have been infected by A/H7N9 and were managed as
outpatients without antiviral prescription. All three patients
quickly recovered after 3-5 days. Nasopharyngeal swabs
collected at the first visit to the ILI sentinel clinics for all three
patients were tested positive for A/H7N9 after their full
recovery.
Patient 2 was a 4 year old child from Shanghai, who developed
a fever of 39°C and mild rhinorrhoea on 31 March 2013, and
was seen in a routine sentinel clinic on 1 April, where a
nasopharyngeal swab taken. He was admitted to hospital on 3
April when the swab tested positive for A/H7N9, andwas started
on oseltamivir 45 mg twice daily for five days. His chest
radiograph on admission (fig 4⇓) and other laboratory findings
showed no abnormalities (table 2⇓). He remained clinically
stable, and his symptoms quickly resolved. When two
consecutive nasopharyngeal samples tested negative on 8 and
9 April, he was discharged on 10 April.
Patient 4 was a 26 year old man from Jiangsu who first had
fever and a productive cough with yellowish sputum on 8 April.
He sought care at a routine sentinel clinic two days later, and
was prescribed 1 g ceftazidime every 6 h. He presented again
on April 12 with fever of 38.5°C, and was admitted to hospital
and started on oseltamivir 75 mg twice daily and moxifloxacin
400 mg once daily. Initial investigation revealed radiological
evidence of left sided pneumonia (fig 5⇓) and mildly elevated
concentrations of serum transaminases (table 2). His
nasopharygeal swab at the sentinel clinic tested positive for
A/H7N9 after his admission. He improved clinically and was
discharged on 26 April 2013.
Discussion
Summary and clinical implications of results
The complete case series of A/H7N9 infections detected to date
through China’s national sentinel surveillance system for
influenza-like illness has provided contrasting clinical
presentations to the generally more severe presentations of
A/H7N9 cases reported so far.7 9 The five patients detected by
the surveillance system were much younger, on average, than
the cohort of people with laboratory confirmed infections (13
years v about 60 years). But both groups otherwise shared
similar epidemiological characteristics—including exposure
history, geographical location, and calendar time of disease
onset. However, none of the five patients had any chronic
underlyingmedical conditions, unlikemany in the general cohort
of confirmed cases.7 9 16 Our report expands on a preliminary
assessment of six people with A/H7N9 infections who were
identified either through the routine sentinel surveillance system
for influenza-like illness or through enhanced surveillance
among inpatients with atypical pneumonia, established as part
of the response to A/H7N9.14 17
Our findings reinforce the need for vigilance to the diverse
presentation that can be associated with A/H7N9 infection. This
vigilance is important not only in the interest of direct patient
care, but also in terms of public health, because a large
proportion of unidentified cases with mild infection in the
community may be a source of infection to other susceptible
people if A/H7N9 develops the capacity for human to human
transmission, thus making an epidemic potentially much more
difficult to control.
Strengths and limitations of the study
Because five (4%) of the 130 patients with laboratory confirmed
infections presented with mild disease and were detected only
by the sentinel surveillance system for influenza-like illness,
our findings provide indirect evidence of a substantial proportion
of mild disease. This proportion would be in keeping with most
influenza strains, with the notable exception of A/H5N1, to
varying degrees. Systematic seroepidemiology studies will
provide definitive evidence in time, by use of a cross-sectional
design and by longitudinal paired sampling. In the interim,
however, formal techniques for statistical inference can give
bounded estimates to inform real time decision making in public
health. Additionally, any simple computation of the “confirmed
case fatality risk”—that is, dividing the number of deaths by
the total number of laboratory confirmed and reported
cases—could be complicated by a denominator that is probably
much larger (as these results suggest), thus upward biasing the
projection of mortality burden in the population.
At the system level, although sentinel surveillance systems for
influenza-like illness are primarily designed for informing
situational awareness rather than actual case finding in an
epidemic setting,1 our results suggest that large scale surveillance
networks in the community can be useful as a population based
sampling tool to enhance understanding of the full spectrum of
disease, especially in the early phase of an evolving epidemic
such as the present one.
Importantly, this report is limited by the lack of associated viral
genetic data. Future work should investigate any potential
divergence in viral characteristics by phylogenetic and deep
sequencing analysis between cases detected by various different
routes—that is, routine surveillance for influenza-like illness
versus direct clinical presentation otherwise.
We thank staff members of the Bureau of Disease Control and
Prevention, Health Emergency Response Office of the National Health
and Family Planning Commission, and provincial and local departments
of health for assisting with administration and data collection; staff
members at county, prefecture, and provincial government offices, and
at the Centers of Disease Control and Prevention in Shanghai, Jiangsu,
Zhejiang, Anhui, Henan, Beijing, Shandong, Jiangxi, Fujian, and Hunan
provinces for assisting with the field investigation, administration, and
data collection.
Contributors: GML and HY conceptualised the study design and
supervised the study. QL, ZG, BC, LF, XX, HJ, ML, JB, JZ, QZ, ZC, YL,
JY, FL, WY, and HY acquired the data. DKMI, QL, PW, MYN, GML,
and HY analysed and interpreted the data. DKMI and PW drafted the
manuscript. All authors critically revised and approved the final
manuscript. DKMI, QL, PW, ZG, and BC contributed equally to this
work. GML and HY are guarantors.
Funding: This study received funding from the US National Institutes of
Health (Comprehensive International Program for Research on AIDS
grant U19 AI51915); the China-US collaborative program on emerging
and re-emerging infectious diseases. The study was also funded by
grants from the Chinese Ministry of Science and Technology (2012
ZX10004-201); the Harvard Center for Communicable DiseaseDynamics
from the National Institute of General Medical Sciences (grant U54
GM088558); the Research Fund for the Control of Infectious Disease,
Food, and Health Bureau (government of the Hong Kong Special
Administrative Region), and the area of excellence scheme of the Hong
Kong University grants committee (grant AoE/M-12/06). The funding
bodies had no role in study design, data collection and analysis,
preparation of the manuscript, or the decision to publish.
Competing interests: All authors have completed the ICMJE uniform
disclosure form at www.icmje.org/coi_disclosure.pdf (available on
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2013;346:f3693 doi: 10.1136/bmj.f3693 (Published 24 June 2013) Page 3 of 10
RESEARCH
What is already known on this topic
The “clinical iceberg” phenomenon of milder cases that escape detection is a common feature of influenza
Most reports of infection from the novel influenza A/H7N9 virus have so far presented a severe clinical picture
It remains unknown whether the clinical iceberg phenomenon applies to A/H7N9
What this study adds
Evidence suggests that there is an important proportion of mild disease, and supports the existence of a clinical iceberg phenomenon
in influenza A/H7N9 infections
Our findings reinforce the need for vigilance to the diverse presentation that can be associated with influenza A/H7N9 infections
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Tables
Table 1| Epidemiological and clinical characteristics of five patients with influenza A/H7N9 identified through routine surveillance for
influenza-like illness in China
Patient 5Patient 4Patient 3Patient 2Patient 1
9262642Age (years)
MaleMaleFemaleMaleMaleSex
FujianJiangsuJiangsuShanghaiShanghaiLocation
UrbanUrbanUrbanUrbanUrbanResidential setting
NoneNoneNoneNoneNoneUnderlying medical conditions
Poultry exposure around
the home
Work place close to live
poultry market
Exposure to pigeonPoultry exposure
around the home
Data unavailableType of exposure
Data unavailable215189No of close contacts traced
26 April 20138 April 20138 April 201331 March 201317 March 2013Date of illness onset
Fever, diarrhoea, malaiseFever, productive coughFever, myalgiaFever, rhinorrhoeaFeverPresenting symptoms
NoYes (left sided)NoNoNoPneumonia (as indicated by lung
consolidation on chest radiograph)
NoNoNoNoNoMechanical ventilation
Time from illness onset to clinical milestone
11111First visit at any medical facility (days)
12111Visit to surveillance sentinel clinic
(days)
Never admitted4Never admitted3Never admittedAdmission to hospital (days)
Not treated with antiviral
drugs
4Not treated with
antiviral drugs
3Not treated with
antiviral drugs
Receiving antiviral treatment (days)
318 (hospital discharge)410 (hospital discharge)5Recovery or hospital discharge (days)
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Table 2| Laboratory and treatment characteristics of patients 2 and 4 with influenza A/H7N9 identified through routine surveillance for
influenza-like illness in China
Patient 4 (moderate infection)Patient 2 (mild infection)
Laboratory findings
5.96.2White blood cell count (109 cells/L)
3.22.6Neutrophils (109 cells/L)
2.43.0Lymphocytes (109 cells /L)
186114Haemoglobin (g/L)
129279Platelets (109 cells /L)
639Alanine transaminase (U/L)*
8724Aspartate transaminase (U/L)*
49.925.0Creatinine (μmol/L)
605.831.0Creatine kinase (U/L)*
1849223Lactate dehydrogenase (U/L)*
3.63.7Potassium (mmol/L)
133.8149Sodium (mmol/L)
Test not doneTest not doneGlucose (mmol/L)
Test not done8.0C reactive protein (nmol/L)
0.3Test not doneFraction of inspired oxygen (FiO2)
62.0Test not doneArterial oxygen partial pressure (PaO2; mm Hg)†
42.0Test not doneArterial carbon dioxide partial pressure (PaCO2, mm Hg)†
206.7Test not donePaO2:FiO2 ratio
Treatment
Oseltamivir (150 mg, twice daily for 4 days; then 75 mg,
twice daily for 4 days)
Oseltamivir (45 mg, twice daily for 5 days)Antiviral drugs
NoNoSteroids
Ceftazidime (1 g, once every 6 h for 3 days); then
moxifloxacin (400 mg, daily for 2 days)
NoAntibiotics
NoNoIntravenous immunoglobulin
*1 U/L=0.0167 µkat/L.
†1 mm Hg=0.133 kPa.
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Figures
Fig 1 Distribution of laboratory confirmed cases of influenza A/H7N9 virus infection in mainland China, by location, between
19 February and 3 May 2013. Red squares=five cases detected through the sentinel surveillance system; blue circles=all
other cases. Provinces are shaded according to population density, and A/H7N9 cases with more recent calendar dates
of illness onset are represented by symbols with darker shades
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Fig 2 Distribution of laboratory confirmed cases of influenza A/H7N9 virus infection in mainland China, by time. Number of
cases by calendar date of illness onset in Shanghai, Jiangsu, Zhejiang, Fujian, and other provinces
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Fig 3 Clinical milestones of patients 1-5 detected through routine sentinel surveillance for influenza-like illness in China.
RT-PCR=reverse transcriptase-polymerase chain reaction
Fig 4 Radiological findings of patient 2 with influenza A/H7N9 infection, identified through routine sentinel surveillance for
influenza-like illness in China
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Fig 5 Radiological findings of patient 4 with influenza A/H7N9 infection, identified through routine sentinel surveillance for
influenza-like illness in China. Chest radiograph on admission shows ground glass opacity at upper and middle lung fields
on patient’s left side
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